Meet our API experts at
the biggest international
pharma event!
Join us at
CPHI Worldwide 2022
November 1-3, 2022 
Messe Frankfurt, Germany | Booth #80B60Our Team at CPhI Worldwide
-
Deepak Sapra
CEO, Pharmaceutical Services And Active Ingredients
-
Nirav K Shah
Vice President and Head - North Asia
-
Rohan Kaushik
Associate Vice President, BD & Portfolio - North Asia
-
Dr. Rajeev Rehani Budhdev
Executive Vice President , API R&D
-
E Sreedhar
Executive VP, API Regulatory Affairs
-
Gustavo Mayrink
Vice President, Sales & Marketing – LATAM
-
Simão Calvete
Head Regulatory Affairs – LATAM
-
Yuri Pereira
Sales & BD Manager- LATAM
-
Kalpesh Kumar Modi
Vice President and Region Head - Europe
-
Pratik Singh Bais
Director, Mexico & Central America
-
Utkarsh Sadashiv Vyas
Director, Portfolio & BD
-
Dr. A Kalyan Chakravarthy
Vice President & Head
-
Puneet Rastogi
Associate VP - US
-
Sumit Kumar
Vice President and Region Head - US
-
Juli Asmonga
Associate VP - US
-
Gunjan Singh
Vice President and Head- US & Europe
-
Khushi Ram
Director, Portfolio Management
-
Ashish Rana
Director - Sales and Marketing - Europe
-
Lionel Bannelier
Associate Vice President - Europe
-
Alok R Joshi
Director, Growth Projects & Peptides
-
Shivakumar Binjawadagi
Head Product Management
-
Ashwinikumar Kulkarni
Associate VP and Head, Global Customer Support and Program Management
-
B Vivek
Executive VP and Global Head Supply, Demand Planning and Delivery
-
Karun Gaur
Vice President - SEMEA
-
Siddhartha Deshpande
Associate Vice president - SEMEA
-
Rohit Dash
Director
-
Kapil Choudhury
Vice President & Head- Strategy, BD, Product management
About CPHI Worldwide 2022
The upcoming edition of CPHI Worldwide will be held at the Messe Frankfurt from November 1st to 3rd. More than 2500 international exhibitors from 170+ countries and around 45,000 professionals, including a significant number of suppliers and decision-makers, are anticipated to participate.
CPhI Worldwide 2022 will offer a unique platform where market leaders can communicate and exchange knowledge with their target audiences and important industry personalities. In addition, there will be opportunities to explore a host of product categories and advanced solutions with state-of-the-art technologies.
About Dr.Reddy’s API Business
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
Sustainability
Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.
Our Achievements
07/10/2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
21/01/2021
Best Supply Chain Team of the Year - Pharma- 2021
03/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
07/10/2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
21/01/2021
Best Supply Chain Team of the Year - Pharma- 2021
03/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
Disclaimer
No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.